Pharmacokinetics, tissue distribution and excretion study of a furostanol glycoside-based standardized fenugreek seed extract in rats

Renal Failure

Volumn 37, Issue 7, 2015, Pages 1208-1218

  Kandhare, Amit D ^a   Bodhankar, Subhash L ^a   Mohan, V ^b   Thakurdesai, Prasad A ^b  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b Indus Biotech Private Limited   (India)

Author keywords

elimination; Furostanol glycoside fraction of Trigonella foenum graecum; HPLC; pharmacokinetics; solid liquid extraction; tissue distribution

Indexed keywords

FENUGREEK EXTRACT; GLYCOSIDE; FENUGREEK SEED MEAL; FUROSTANOL GLYCOSIDE; PLANT EXTRACT; STEROL;

ANIMAL EXPERIMENT; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG BRAIN LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EXCRETION; DRUG TISSUE LEVEL; ELIMINATION HALF-LIFE; FECES; FENUGREEK; LIMIT OF QUANTITATION; MALE; NONHUMAN; PLANT SEED; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; THIN LAYER CHROMATOGRAPHY; TISSUE DISTRIBUTION; TISSUE HOMOGENATE; URINARY EXCRETION; ANIMAL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ORAL DRUG ADMINISTRATION; PROCEDURES; SOLID PHASE EXTRACTION; STATISTICAL MODEL; TRIGONELLA; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLYCOSIDES; LINEAR MODELS; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; SOLID PHASE EXTRACTION; STEROLS; TISSUE DISTRIBUTION; TRIGONELLA;

EID: 84941929731     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2015.1057472     Document Type: Article

References (40)

1. Yang CL, Or TC, Ho MH, Lau AS. Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis. Clin Rev Allergy Immunol. 2013;44(3):284-300.
2. Omeish AF, Abbadi W, Ghanma IM, et al. Hospital-based study on the use of herbal medicine in patients with coronary artery disease in Jordan. Hospital. 2011;67(7):683-687.
3. Saad B, Azaizeh H, Said O. Tradition and perspectives of Arab herbal medicine: A review. Evid Based Complement Alternat Med. 2005;2(4):475-479.
4. Tang J, Song X, Zhu M, Zhang J. Study on the pharmacokinetics drug-drug interaction potential of Glycyrrhiza uralensis, a traditional Chinese medicine, with lidocaine in rats. Phytother Res. 2009;23(5):603-607.
5. Kandhare A, Patil MV, Bodhankar S. L-Arginine attenuates the ethylene glycol induced urolithiasis in uninephrectomized hypertensive rats: Role of KIM-1, NGAL and NOs. Renal Fail. 2015; 37(4):709-721.
6. Kandhare AD, Ghosh P, Bodhankar SL. Naringin, a flavanone glycoside, promotes angiogenesis and inhibits endothelial apoptosis through modulation of inflammatory and growth factor expression in diabetic foot ulcer in rats. Chem Biol Interact. 2014;219C: 101-112.
7. Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL. Elucidation of molecular mechanism involved in neuroprotective effect of Coenzyme Q10 in alcohol induced neuropathic pain. Fundam Clin Pharmacol. 2013;27(6):603-622.
8. Visnagri A, Kandhare A, Bodhankar S. Renoprotective effect of berberine via intonation on apoptosis and mitochondrial dependent pathway in renal ischemia reperfusion induced mutilation. Renal Fail. 2015;37(3):482-493.
9. Bashri G, Singh VP, Prasad SM. A review on nutritional and antioxidant values, and medicinal properties of Trigonella foenumgraecum L. Biochem Pharmacol. 2013;2(3):118-120.
10. Snehlata HS, Payal DR. Fenugreek (Trigonella foenumgraecum L.): An overview. Int J Curr Pharm Rev Res. 2012; 2(4):169-187.
11. Ulbricht C, Basch E, Burke D, et al. Fenugreek (Trigonella foenumgraecum L. Leguminosae): An evidence-based systematic review by the natural standard research collaboration. J Herbal Pharmacother. 2007;7(3-4):143-177.
12. Basu TK, Srichamroen A. Chapter 28-Health benefits of fenugreek (Trigonella foenum-graecum leguminosse). In: Watson RR, Preedy VR, eds. Bioactive Foods in Promoting Health. San Diego: Academic Press; 2010:425-435.
13. Smith M. Therapeutic applications of fenugreek. Altern Med Rev. 2003;8(1):20-27.
14. Al-Habori M, Raman A. Antidiabetic and hypocholesterolaemic effects of fenugreek. Phytothe Res. 1998;12(4):233-242.
15. Raghuram T, Sharma R, Sivakumar B, Sahay B. Effect of fenugreek seeds on intravenous glucose disposition in non-insulin dependent diabetic patients. Phytother Res. 1994;8(2):83-86.
16. Madar Z, Abel R, Samish S, Arad J. Glucose-lowering effect of fenugreek in non-insulin dependent diabetics. Eur J Clin Nutr. 1988;42(1):51-54.
17. Al-Jasass FM, Al-Jasser MS. Chemical composition and fatty acid content of some spices and herbs under Saudi Arabia conditions. Scientific World J. 2012;2012:1-5.
18. Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci. 2004; 96(3):229-245.
19. Lee SJ, Son KH, Chang HW, et al. Antiinflammatory activity of naturally occurring flavone and flavonol glycosides. Arch Pharm Res. 1993;16(1):25-28.
20. Kawabata T, Cui MY, Hasegawa T, Takano F, Ohta T. Antiinflammatory and anti-melanogenic steroidal saponin glycosides from Fenugreek (Trigonella foenum-graecum L.) seeds. Planta Med. 2011;77(7):705-710.
21. Mandegary A, Pournamdari M, Sharififar F, Pournourmohammadi S, Fardiar R, Shooli S. Alkaloid and flavonoid rich fractions of fenugreek seeds (Trigonella foenum-graecum L.) with antinociceptive and anti-inflammatory effects. Food Chem Toxicol. 2012; 50(7):2503-2507.
22. Vasil'eva I, Vaniushkin S, Zinov'eva S, Udalova Z, Bolychevtseva I, Paseshnichenko V. Photosynthetic pigments of tomato under conditions of biotic stress and effects of furostanol glycosides. Prikl Biokhim Mikrobiol. 2002;39(6):689-696.
23. Dubinskaia V, Strelkova L, Vasil'eva I, Nikolaeva S, Rebrov L, Paseshnichenko V. Anabolic properties of furostanol glycosides from Dioscorea deltoidea wall. Biull Eksp Biol Med. 1998; 126(8):178-181.
24. Park S-W, Lee C-H, Shin D-H, Bang N-S, Lee S-M. Effect of SA1, a herbal formulation, on sexual behavior and penile erection. Biol Pharm Bull. 2006;29(7):1383-1386.
25. Valette G, Sauvaire Y, Baccou J-C, Ribes G. Hypocholesterolaemic effect of fenugreek seeds in dogs. Atherosclerosis. 1984; 50(1):105-111.
26. Aswar U, Bodhankar SL, Mohan V, Thakurdesai PA. Effect of furostanol glycosides from Trigonella foenum-graecum on the reproductive system of male albino rats. Phytother Res. 2010; 24(10):1482-1488.
27. Lu T, Yang J, Gao X, et al. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metab Dispos. 2008;36(8):1578-1586.
28. Bhaskaran S, Mohan V, Inventors; Indus Biotech Private Limited, Pune, India, assignee. A composition for treating autoimmune disorders and methods thereof. US patent WO2012150486 A1. Nov 8, 2012; 2012.
29. U.S. Department of Health and Human Services. Guidance for industry, bioanalytical method validation; 2001. Available at: http:// www.fda.gov/cvm.
30. Bhaskaran S, Vishwaraman M. Composition and method thereof. Google Patents; 2013.
31. Tian S, He G, Song J, et al. Pharmacokinetic study of baicalein after oral administration in monkeys. Fitoterapia. 2012; 83(3):532-540.
32. Liang L, Liu X, Wang Q, Cheng S, Zhang S, Zhang M. Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,40-tri-O-acetylresveratrol in rats. Phytomedicine. 2013;20(6):558-563.
33. Kandhare AD, Raygude KS, Ghosh P, Gosavi TP, Bodhankar SL. Patentability of animal models: India and the Globe. Int J Pharm BiolArch. 2011;2(4):1024-1032.
34. Zhao L, Chen Z, Zhao Q, et al. Developmental toxicity and genotoxicity studies of wogonin. Regul Toxicol Pharmacol. 2011; 60(2):212-217.
35. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia. 2012;83(4):650-659.
36. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Therapeutic role of curcumin in prevention of biochemical and behavioral aberration induced by alcoholic neuropathy in laboratory animals. Neurosci Lett. 2012; 511(1):18-22.
37. Kandhare AD, Shivakumar V, Rajmane A, Ghosh P, Bodhankar SL. Evaluation of the neuroprotective effect of chrysin via modulation of endogenous biomarkers in a rat model of spinal cord injury. J Nat Med. 2014;68(3):586-603.
38. Brazier NC, Levine MA. Drug-herb interaction among commonly used conventional medicines: A compendium for health care professionals. Am J Ther. 2003;10(3):163-169.
39. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol Sci. 2009;30(2):85-94.
40. Jones QR, Warford J, Rupasinghe H, Robertson GS. Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol Sci. 2012;33(11):602-610.